2024 年至 2031 年血管摄影导管市场（依产品、应用及地区划分）

2024 年至 2031 年血管摄影导管市场评估

由于多种因素，血管造影导管市场的需求正在快速成长。心血管疾病（主要是冠状动脉疾病和中风）的发生率不断上升，促使对诊断和介入程序的需求增加。这些导管在可视化血管和执行血管成形术和支架置入术等微创手术中发挥关键作用。预计2024年市场规模将超过13.7亿美元，2031年将达到约24.2亿美元。

导管技术的进步，包括材料的改进、直径的减少和成像能力的增强，使得导管更有效、侵入性更小，从而进一步推动了需求。人口老化日益加剧，使人们更容易患心血管疾病，从而促进了市场扩张。由于对具有成本效益且高效的血管造影导管的需求不断增加，预计 2024 年至 2031 年期间市场复合年增长率将达到 7.38%。

血管摄影导管市场定义/概述

血管造影导管是一种专门的医疗设备，用于将造影剂注入血管动脉，以便在血管造影过程中在 X 光影像上看到造影剂。这些导管有助于观察心臟动脉、静脉和心室的结构和功能，使临床医生能够检测和治疗多种心血管疾病，包括阻塞、动脉瘤和先天性异常。血管摄影导管是细而柔软的管子，透过动脉（最常见的是股动脉或桡动脉）插入并使用影像技术引导到所需区域。

血管摄影导管主要用于诊断和介入性心臟病学的冠状动脉、週边和脑血管造影。这些导管也用于血管成形术、支架植入术和栓塞术等治疗程序。随着影像技术的发展以及更灵活、生物相容性和可操纵性的导管，血管造影导管的未来可能会包括更精确和更少侵入性的程序。由于全球心血管疾病发生率不断上升及影像引导手术的增多，血管造影导管的需求预计持续上升，这可能是由于机器人辅助导管手术的发展及即时影像技术的进步。

导管设计技术的进步会推动血管摄影导管市场的发展吗？

导管设计的进步，尤其是微导管和可操纵导管等创新，正在推动血管摄影导管市场的发展。这些技术进步将使复杂血管网路中的导航更加精确，从而提高血管造影程序的准确性和安全性。FDA 在 2020 年批准了 43 种新的心血管设备，其中许多涉及导管技术，显示这些先进技术的利用率有所提高。

老年人口可能会刺激血管摄影导管市场的发展。随着世界人口老化，冠状动脉疾病和动脉粥状硬化等心血管疾病的盛行率不断增加，这些疾病通常可以透过治疗性血管摄影进行检测和治疗。根据联合国预测，到 2050 年，65 岁及以上人口预计将从 2019 年的 7.03 亿增加一倍达到 15 亿。老年人口的大幅增加预计将刺激对心血管检测和治疗的需求，从而加速血管造影导管市场的扩张。

高昂的手术费用会阻碍血管摄影导管市场的成长吗？

预计血管造影导管市场的成长将受到血管摄影手术高成本的影响。这些价格可能会限制获得这些程序的机会并减少总需求，特别是在医疗资源有限的中低收入国家。医院和医疗机构在投资先进的血管摄影设备和导管时也可能面临成本限制。即使在已开发国家，患者的费用（特别是在保险覆盖有限的系统中）也可能导致医疗程序的延迟或缩减，从而限制市场成长。

风险和併发症可能会影响血管摄影导管市场的成长。由于这些导管用于关键的心血管手术，感染、过敏反应、血管损伤和造影剂诱发肾臟病的风险可能会引起患者和医疗保健专业人员的担忧。随着监管审查的加强和医疗保健专业人员转向替代诊断方法，人们对这些风险的认识可能会提高，并限制市场扩张。此外，安全问题将影响市场动态，推动对更安全解决方案的需求，同时增加成本，这可能会阻碍广泛采用。

目录

第 1 章全球血管摄影导管市场简介

• 市场概况
• 调查范围
• 先决条件

第 2 章 执行摘要

第3章 VERIFIED MARKET RESEARCH研究方法

• 数据挖掘
• 验证
• 一次资料
• 数据源列表

第4章 血管摄影导管全球市场展望

• 概述
• 市场动态
• 促进因素
• 阻碍因素
• 机会
• 波特的五力模型
• 价值链分析

第 5 章全球血管摄影导管市场（按产品）

• 刻划球囊导管
• 常规导管
• DEB导管
• 切割球囊导管

第6章 全球血管摄影导管市场（依应用）

• 影像中心
• 医院
• 诊所

第7章 全球血管摄影导管市场（按地区）

• 北美
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 德国
• 英国
• 法国
• 欧洲其他地区
• 亚太地区
• 中国
• 日本
• 印度
• 亚太其他地区
• 世界其他地区
• 拉丁美洲
• 中东/非洲

第 8 章全球血管摄影导管市场：竞争格局

• 概述
• 各公司市场排名
• 主要发展策略

第9章 公司简介

• B. Braun
• Boston Scientific
• C. R. Bard
• Medtronic
• Asahi Intecc
• Atrium Medical
• Abbott Laboratories
• Abiomed
• Acrostak
• Smiths Medical
• Oscor
• Claret Medical
• Contego Medical
• Cook Group

第10章 附录

• 相关报导

Angiography Catheters Market Valuation - 2024-2031

The angiography catheters market is experiencing a surge in demand due to several factors. Primarily, the increasing prevalence of cardiovascular diseases, such as coronary artery disease and stroke, has led to a greater need for diagnostic and interventional procedures. These catheters play a crucial role in visualizing blood vessels and performing minimally invasive treatments like angioplasty and stent placement. The market size surpass USD 1.37 Billion valued in 2024 to reach a valuation of aroundUSD 2.42 Billion by 2031.

Advancements in catheter technology, including improved materials, smaller diameters, and enhanced imaging capabilities, have made them more effective and less invasive, further driving demand. The growing aging population, which is more susceptible to cardiovascular diseases, is contributing to the market's expansion. The rising demand for cost-effective and efficient angiography catheters is enabling the market to grow at aCAGR of 7.38% from 2024 to 2031.

Angiography Catheters Market: Definition/ Overview

Angiography catheters are specialized medical devices that inject contrast media into blood arteries to make them visible on X-ray imaging during angiography operations. These catheters aid in seeing the structure and function of the heart's arteries, veins, and chambers, allowing clinicians to detect and treat a wide range of cardiovascular diseases including blockages, aneurysms, and congenital anomalies. Angiography catheters are flexible, thin tubes that are put via an artery, most commonly the femoral or radial artery, and directed to the desired region using imaging techniques.

Angiography catheters are primarily used in diagnostic and interventional cardiology to perform coronary, peripheral, and cerebral angiograms. These catheters are also used in therapeutic procedures like angioplasty, stent implantation, and embolization. With developments in imaging technology and the development of more flexible, biocompatible, and steerable catheters, the future of angiography catheters will involve more precise and least invasive procedures. The growing global prevalence of cardiovascular illnesses, combined with an increase in image-guided therapies, predicts that demand for angiography catheters will continue to climb, possibly due to developments in robotic-assisted catheterization and increased real-time imaging technology.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will the Advancement in Technology of Catheter Design Fuel the Angiography Catheters Market?

Advancements in catheter design, notably innovations such as micro-catheters and steerable catheters, are propelling the angiography catheter market. These technical advancements enable more precise navigation in complex vascular networks, improving the accuracy and safety of angiography treatments. The FDA's approval of 43 new cardiovascular devices in 2020, many of which involve catheter technology, demonstrates the rising use of these advanced technologies.

The elderly population is likely to fuel the angiography catheter market. As the world population ages, the prevalence of cardiovascular disorders such as coronary artery disease and atherosclerosis rises, which are frequently detected and treated via angiography treatments. According to the United Nations, the number of individuals aged 65 and more is predicted to double from 703 million in 2019 to 1.5 billion by 2050. This considerable increase in the older population will fuel demand for cardiovascular tests and therapies, accelerating the expansion of the angiography catheters market.

Will the High-Cost Associated with Procedures Hamper the Growth of the Angiography Catheters Market?

The high cost of angiography operations is anticipated to have an impact on market growth for angiography catheters. These prices can limit access to such procedures, particularly in low- and middle-income countries with limited healthcare resources, lowering total demand. Hospitals and healthcare facilities may also face cost constraints when investing in sophisticated angiography equipment and catheters. Patient expenses, even in industrialized countries, may result in delayed or curtailed procedures, especially in systems with limited insurance coverage, limiting market growth.

Risks and complications can have an impact on the growth of the angiography catheter market. These catheters are utilized in crucial cardiovascular procedures, and any dangers, including infections, allergic reactions, blood vessel damage, or contrast-induced nephropathy, might cause concern among both patients and healthcare personnel. Increased awareness of these dangers may restrict market expansion as regulatory scrutiny intensifies and healthcare professionals turn to alternate diagnostic methods. Furthermore, safety concerns may influence market dynamics, pushing demand for safer solutions while potentially increasing costs, and discouraging widespread use.

Category-Wise Acumens

Will the Integration of Drug-Eluting Technology Drive the Drug-Eluting Balloon Catheters Segments for the Angiography Catheters Market?

Drug-

eluting balloon catheter segments dominate the angiography catheters market. The integration of drug-eluting technology is projected to propel the drug-eluting balloon catheters sector of the angiography catheters market. Drug-eluting balloon catheters direct therapeutic substances to the target site, lowering restenosis and enhancing patient outcomes in vascular procedures. This technology, together with increased rates of cardiovascular disease and a shift toward minimally invasive procedures, is expected to increase demand and expand the market for these advanced catheters.

The prevalence of cardiovascular illnesses is projected to drive the expansion of the drug-eluting balloon (DEB) catheter segment in the angiography catheter market. As cardiovascular disorders such as coronary artery disease and peripheral artery disease become more common, owing to aging populations and lifestyle choices, there is a greater need for better treatment alternatives. DEB catheters, which release medicines to prevent arterial re-narrowing (restenosis) during angioplasty, are a targeted and successful treatment that reduces the need for stent insertion. This makes them an appealing alternative for healthcare professionals, accelerating their adoption in response to the growing burden of cardiovascular disease.

Will the High Volume of Patients Requiring Cardiovascular Procedures Accelerate the Hospital's Segment for the Angiography Catheters Market?

Hospital's segment fastest leading in the angiography catheters market. The large volume of patients requiring cardiovascular operations is expected to boost the angiography catheters market in the hospital segment. As the prevalence of cardiovascular illnesses rises worldwide, there is an increasing demand for diagnostic and interventional techniques that rely primarily on angiography catheters. These devices are critical for diagnosing and treating coronary artery disease and peripheral vascular disease. Furthermore, advances in catheter technology and increased healthcare investments in cardiovascular care are propelling this market forward, as hospitals strive to improve diagnostic accuracy and treatment efficacy.

The availability of advanced medical equipment and qualified workers is expected to drive the hospital segment's growth in the angiography catheter market. This expansion is being driven by the rising need for precise diagnostic and therapeutic treatments that necessitate high-quality angiography catheters. Advanced equipment improves the accuracy and efficiency of these treatments, while trained clinicians make the best use of the technology, resulting in better patient results. Furthermore, the increased prevalence of cardiovascular disorders, as well as the necessity for sophisticated imaging procedures to manage these conditions, are driving up demand for advanced angiography catheters in hospitals.

Country/Region-wise Acumens

Will Improvement in Health Infrastructure in North America Boost the Angiography Catheters Market?

North America is dominating in angiography catheters market thanks to its improved health infrastructure. The growing progress of healthcare infrastructure will drive the North American angiography catheters market. North America excels in this market due to its advanced healthcare infrastructure, large patient population, and high frequency of cardiovascular disorders. With cardiovascular disease expected to affect more than 40% of the US population by 2030, the demand for sophisticated diagnostic tools such as angiography catheters will increase. Furthermore, the strong presence of major industry players and ongoing advancements will drive market expansion in the region.

The North American market for angiography catheters is predicted to rise due to an aging population. According to the United States Census Bureau, the baby boomer group will account for 73 million of the senior population by 2030. Because cardiovascular disease risk rises with age, this demographic trend is projected to boost the demand for diagnostic equipment such as angiography catheters. As a result, North America's expanding elderly population will significantly drive market demand, as more individuals will need cardiovascular evaluations and treatments.

Will Increasing Awareness of Cardiovascular Health Lead the Asia Pacific's Angiography Catheters Market?

Asia Pacific is rapidly growing in the angiography catheters market owing to its increased awareness of cardiovascular health. The increasing frequency of cardiovascular diseases (CVDs), which are the main cause of death worldwide, particularly in Asia, accounts for 35% of all deaths. As people become more conscious of their cardiovascular health, they seek diagnostic and interventional procedures, which increases the demand for angiography catheters. Furthermore, the region's aging population and expanding healthcare facilities drive up demand, positioning the market for significant development.

Government initiatives are propelling the Asia-Pacific angiography catheters market. Efforts to enhance healthcare access and affordability are driving market growth, as demonstrated in China, where coronary angiography operations increased by about 50% between 2015 and 2019, owing to rising healthcare costs and an aging population. Similarly, India's rising prevalence of cardiovascular illnesses, which is expected to exceed 103 million cases by 2030, and Japan's consistent increase in percutaneous coronary interventions (PCI) drive demand for angiography catheters, generating significant potential possibilities in the area.

Competitive Landscape

The angiography catheters market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the optogenetics market include:

• Medtronic
• Boston Scientific Corporation
• Terumo Medical Corporation
• Merit Medical Systems
• AngioDynamics
• Cardinal Health
• Braun Melsungen AG
• Becton
• Dickinson and Company

Latest Developments

• In February 2022, Teleflex received Food and Drug Administration clearance for an expanded indication for specialty catheter and coronary guidewire use in crossing chronic total occlusion percutaneous coronary interventions.
• In October 2022, The HELIOSTAR Balloon Ablation Catheter is indicated for cardiac ablation and catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria beginning when combined with a suitable multi-channel RF generator.
• In July 2021, Philips announced the first minimally-invasive heart procedure using its real-time 3D intracardiac echocardiography catheter

TABLE OF CONTENTS

1. Introduction of Global Angiography Catheters Market

• Overview of the Market
• Scope of Report
• Assumptions

2. Executive Summary

3. Research Methodology of Verified Market Research

• Data Mining
• Validation
• Primary Interviews
• List of Data Sources

4. Global Angiography Catheters Market Outlook

• Overview
• Market Dynamics
• Drivers
• Restraints
• Opportunities
• Porters Five Force Model
• Value Chain Analysis

5. Global Angiography Catheters Market, By Product

• Scoring Balloon Catheters
• Conventional Catheters
• DEB Catheters
• Cutting Balloon Catheters

6. Global Angiography Catheters Market, By Application

• ASCs
• Hospitals
• Clinics

7. Global Angiography Catheters Market, By Geography

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• France
• Rest of Europe
• Asia Pacific
• China
• Japan
• India
• Rest of Asia Pacific
• Rest of the World
• Latin America
• Middle East & Africa

8. Global Angiography Catheters Market Competitive Landscape

• Overview
• Company Market Ranking
• Key Development Strategies

9. Company Profiles

• B. Braun
• Boston Scientific
• C. R. Bard
• Medtronic
• Asahi Intecc
• Atrium Medical
• Abbott Laboratories
• Abiomed
• Acrostak
• Smiths Medical
• Oscor
• Claret Medical
• Contego Medical
• Cook Group

10. Appendix

• Related Reports